Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Wendy Macklin to Oligodendroglia

This is a "connection" page, showing publications Wendy Macklin has written about Oligodendroglia.

 
Connection Strength
 
 
 
13.329
 
  1. Brown TL, Hashimoto H, Finseth LT, Wood TL, Macklin WB. PAK1 Positively Regulates Oligodendrocyte Morphology and Myelination. J Neurosci. 2021 03 03; 41(9):1864-1877.
    View in: PubMed
    Score: 0.648
  2. Adams KL, Dahl KD, Gallo V, Macklin WB. Intrinsic and extrinsic regulators of oligodendrocyte progenitor proliferation and differentiation. Semin Cell Dev Biol. 2021 08; 116:16-24.
    View in: PubMed
    Score: 0.637
  3. Brown TL, Macklin WB. The Actin Cytoskeleton in Myelinating Cells. Neurochem Res. 2020 Mar; 45(3):684-693.
    View in: PubMed
    Score: 0.569
  4. Ahrendsen JT, Harlow DE, Finseth LT, Bourne JN, Hickey SP, Gould EA, Culp CM, Macklin WB. The Protein Tyrosine Phosphatase Shp2 Regulates Oligodendrocyte Differentiation and Early Myelination and Contributes to Timely Remyelination. J Neurosci. 2018 01 24; 38(4):787-802.
    View in: PubMed
    Score: 0.522
  5. Hussain R, Macklin WB. Integrin-Linked Kinase (ILK) Deletion Disrupts Oligodendrocyte Development by Altering Cell Cycle. J Neurosci. 2017 01 11; 37(2):397-412.
    View in: PubMed
    Score: 0.490
  6. Dai J, Bercury KK, Jin W, Macklin WB. Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development. J Neurosci. 2015 Dec 02; 35(48):15875-93.
    View in: PubMed
    Score: 0.454
  7. Harlow DE, Saul KE, Komuro H, Macklin WB. Myelin Proteolipid Protein Complexes with av Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression. J Neurosci. 2015 Aug 26; 35(34):12018-32.
    View in: PubMed
    Score: 0.446
  8. Dai J, Bercury KK, Ahrendsen JT, Macklin WB. Olig1 function is required for oligodendrocyte differentiation in the mouse brain. J Neurosci. 2015 Mar 11; 35(10):4386-402.
    View in: PubMed
    Score: 0.432
  9. Bercury KK, Macklin WB. Dynamics and mechanisms of CNS myelination. Dev Cell. 2015 Feb 23; 32(4):447-58.
    View in: PubMed
    Score: 0.430
  10. Preston MA, Macklin WB. Zebrafish as a model to investigate CNS myelination. Glia. 2015 Feb; 63(2):177-93.
    View in: PubMed
    Score: 0.418
  11. Dai J, Bercury KK, Macklin WB. Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation. Glia. 2014 Dec; 62(12):2096-109.
    View in: PubMed
    Score: 0.413
  12. Bercury KK, Dai J, Sachs HH, Ahrendsen JT, Wood TL, Macklin WB. Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination. J Neurosci. 2014 Mar 26; 34(13):4466-80.
    View in: PubMed
    Score: 0.404
  13. Harlow DE, Saul KE, Culp CM, Vesely EM, Macklin WB. Expression of proteolipid protein gene in spinal cord stem cells and early oligodendrocyte progenitor cells is dispensable for normal cell migration and myelination. J Neurosci. 2014 Jan 22; 34(4):1333-43.
    View in: PubMed
    Score: 0.399
  14. Harlow DE, Macklin WB. Inhibitors of myelination: ECM changes, CSPGs and PTPs. Exp Neurol. 2014 Jan; 251:39-46.
    View in: PubMed
    Score: 0.393
  15. Ahrendsen JT, Macklin W. Signaling mechanisms regulating myelination in the central nervous system. Neurosci Bull. 2013 Apr; 29(2):199-215.
    View in: PubMed
    Score: 0.378
  16. Wood TL, Bercury KK, Cifelli SE, Mursch LE, Min J, Dai J, Macklin WB. mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development. ASN Neuro. 2013 Mar 19; 5(1):e00108.
    View in: PubMed
    Score: 0.376
  17. Pedraza CE, Monk R, Lei J, Hao Q, Macklin WB. Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitors. Glia. 2008 Sep; 56(12):1339-52.
    View in: PubMed
    Score: 0.275
  18. Gudz TI, Komuro H, Macklin WB. Glutamate stimulates oligodendrocyte progenitor migration mediated via an alphav integrin/myelin proteolipid protein complex. J Neurosci. 2006 Mar 01; 26(9):2458-66.
    View in: PubMed
    Score: 0.231
  19. Yoshida M, Macklin WB. Oligodendrocyte development and myelination in GFP-transgenic zebrafish. J Neurosci Res. 2005 Jul 01; 81(1):1-8.
    View in: PubMed
    Score: 0.220
  20. Almeida AR, Macklin WB. Early myelination involves the dynamic and repetitive ensheathment of axons which resolves through a low and consistent stabilization rate. Elife. 2023 04 20; 12.
    View in: PubMed
    Score: 0.189
  21. Dahl KD, Almeida AR, Hathaway HA, Bourne J, Brown TL, Finseth LT, Wood TL, Macklin WB. mTORC2 Loss in Oligodendrocyte Progenitor Cells Results in Regional Hypomyelination in the Central Nervous System. J Neurosci. 2023 01 25; 43(4):540-558.
    View in: PubMed
    Score: 0.184
  22. Gudz TI, Schneider TE, Haas TA, Macklin WB. Myelin proteolipid protein forms a complex with integrins and may participate in integrin receptor signaling in oligodendrocytes. J Neurosci. 2002 Sep 01; 22(17):7398-407.
    View in: PubMed
    Score: 0.181
  23. Mallon BS, Shick HE, Kidd GJ, Macklin WB. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci. 2002 Feb 01; 22(3):876-85.
    View in: PubMed
    Score: 0.174
  24. Fuss B, Afshari FS, Colello RJ, Macklin WB. Normal CNS myelination in transgenic mice overexpressing MHC class I H-2L(d) in oligodendrocytes. Mol Cell Neurosci. 2001 Aug; 18(2):221-34.
    View in: PubMed
    Score: 0.168
  25. Kohnke S, Buller S, Nuzzaci D, Ridley K, Lam B, Pivonkova H, Bentsen MA, Alonge KM, Zhao C, Tadross J, Holmqvist S, Shimizu T, Hathaway H, Li H, Macklin W, Schwartz MW, Richardson WD, Yeo GSH, Franklin RJM, Karadottir RT, Rowitch DH, Blouet C. Nutritional regulation of oligodendrocyte differentiation regulates perineuronal net remodeling in the median eminence. Cell Rep. 2021 07 13; 36(2):109362.
    View in: PubMed
    Score: 0.167
  26. Flores AI, Mallon BS, Matsui T, Ogawa W, Rosenzweig A, Okamoto T, Macklin WB. Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci. 2000 Oct 15; 20(20):7622-30.
    View in: PubMed
    Score: 0.159
  27. Musah AS, Brown TL, Jeffries MA, Shang Q, Hashimoto H, Evangelou AV, Kowalski A, Batish M, Macklin WB, Wood TL. Mechanistic Target of Rapamycin Regulates the Oligodendrocyte Cytoskeleton during Myelination. J Neurosci. 2020 04 08; 40(15):2993-3007.
    View in: PubMed
    Score: 0.152
  28. Fuss B, Mallon B, Phan T, Ohlemeyer C, Kirchhoff F, Nishiyama A, Macklin WB. Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev Biol. 2000 Feb 15; 218(2):259-74.
    View in: PubMed
    Score: 0.152
  29. Ornelas IM, Khandker L, Wahl SE, Hashimoto H, Macklin WB, Wood TL. The mechanistic target of rapamycin pathway downregulates bone morphogenetic protein signaling to promote oligodendrocyte differentiation. Glia. 2020 06; 68(6):1274-1290.
    View in: PubMed
    Score: 0.151
  30. Preston MA, Finseth LT, Bourne JN, Macklin WB. A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination. Glia. 2019 04; 67(4):650-667.
    View in: PubMed
    Score: 0.141
  31. Fuss B, Baba H, Phan T, Tuohy VK, Macklin WB. Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J Neurosci. 1997 Dec 01; 17(23):9095-103.
    View in: PubMed
    Score: 0.130
  32. Neri CL, Duchala CS, Macklin WB. Expression of molecular chaperones and vesicle transport proteins in differentiating oligodendrocytes. J Neurosci Res. 1997 Dec 01; 50(5):769-80.
    View in: PubMed
    Score: 0.130
  33. McLane LE, Bourne JN, Evangelou AV, Khandker L, Macklin WB, Wood TL. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination. J Neurosci. 2017 08 02; 37(31):7534-7546.
    View in: PubMed
    Score: 0.127
  34. Trapp BD, Nishiyama A, Cheng D, Macklin W. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol. 1997 Apr 21; 137(2):459-68.
    View in: PubMed
    Score: 0.125
  35. Liu Y, Given KS, Harlow DE, Matschulat AM, Macklin WB, Bennett JL, Owens GP. Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination. Acta Neuropathol Commun. 2017 03 24; 5(1):25.
    View in: PubMed
    Score: 0.124
  36. Verden D, Macklin WB. Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations. J Neurosci Res. 2016 12; 94(12):1411-1420.
    View in: PubMed
    Score: 0.120
  37. Ahrendsen JT, Grewal HS, Hickey SP, Culp CM, Gould EA, Shimizu T, Strnad FA, Traystman RJ, Herson PS, Macklin WB. Juvenile striatal white matter is resistant to ischemia-induced damage. Glia. 2016 11; 64(11):1972-86.
    View in: PubMed
    Score: 0.119
  38. Duchala CS, Asotra K, Macklin WB. Expression of cell surface markers and myelin proteins in cultured oligodendrocytes from neonatal brain of rat and mouse: a comparative study. Dev Neurosci. 1995; 17(2):70-80.
    View in: PubMed
    Score: 0.107
  39. Asotra K, Macklin WB. Developmental expression of protein kinase C isozymes in oligodendrocytes and their differential modulation by 4 beta-phorbol-12,13-dibutyrate. J Neurosci Res. 1994 Oct 15; 39(3):273-89.
    View in: PubMed
    Score: 0.105
  40. Sachs HH, Bercury KK, Popescu DC, Narayanan SP, Macklin WB. A new model of cuprizone-mediated demyelination/remyelination. ASN Neuro. 2014; 6(5).
    View in: PubMed
    Score: 0.105
  41. Baba H, Fuss B, Watson JB, Zane LT, Macklin WB. Identification of novel mRNAs expressed in oligodendrocytes. Neurochem Res. 1994 Aug; 19(8):1091-9.
    View in: PubMed
    Score: 0.103
  42. Wahl SE, McLane LE, Bercury KK, Macklin WB, Wood TL. Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. J Neurosci. 2014 Mar 26; 34(13):4453-65.
    View in: PubMed
    Score: 0.101
  43. Zhao X, Dai J, Ma Y, Mi Y, Cui D, Ju G, Macklin WB, Jin W. Dynamics of ten-eleven translocation hydroxylase family proteins and 5-hydroxymethylcytosine in oligodendrocyte differentiation. Glia. 2014 Jun; 62(6):914-26.
    View in: PubMed
    Score: 0.100
  44. Asotra K, Macklin WB. Protein kinase C activity modulates myelin gene expression in enriched oligodendrocytes. J Neurosci Res. 1993 Apr 01; 34(5):571-88.
    View in: PubMed
    Score: 0.094
  45. Hussain R, Ghoumari AM, Bielecki B, Steibel J, Boehm N, Liere P, Macklin WB, Kumar N, Habert R, Mhaouty-Kodja S, Tronche F, Sitruk-Ware R, Schumacher M, Ghandour MS. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. Brain. 2013 Jan; 136(Pt 1):132-46.
    View in: PubMed
    Score: 0.093
  46. Inamura N, Sugio S, Macklin WB, Tomita K, Tanaka KF, Ikenaka K. Gene induction in mature oligodendrocytes with a PLP-tTA mouse line. Genesis. 2012 May; 50(5):424-8.
    View in: PubMed
    Score: 0.086
  47. Macklin WB, Gardinier MV, Obeso ZO, King KD, Wight PA. Mutations in the myelin proteolipid protein gene alter oligodendrocyte gene expression in jimpy and jimpymsd mice. J Neurochem. 1991 Jan; 56(1):163-71.
    View in: PubMed
    Score: 0.081
  48. LeVine SM, Macklin WB. Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J Neurosci Res. 1990 Aug; 26(4):508-12.
    View in: PubMed
    Score: 0.078
  49. Tsai HH, Macklin WB, Miller RH. Distinct modes of migration position oligodendrocyte precursors for localized cell division in the developing spinal cord. J Neurosci Res. 2009 Nov 15; 87(15):3320-30.
    View in: PubMed
    Score: 0.075
  50. Narayanan SP, Flores AI, Wang F, Macklin WB. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci. 2009 May 27; 29(21):6860-70.
    View in: PubMed
    Score: 0.072
  51. Paez PM, Fulton DJ, Spreuer V, Handley V, Campagnoni CW, Macklin WB, Colwell C, Campagnoni AT. Golli myelin basic proteins regulate oligodendroglial progenitor cell migration through voltage-gated Ca2+ influx. J Neurosci. 2009 May 20; 29(20):6663-76.
    View in: PubMed
    Score: 0.072
  52. Flores AI, Narayanan SP, Morse EN, Shick HE, Yin X, Kidd G, Avila RL, Kirschner DA, Macklin WB. Constitutively active Akt induces enhanced myelination in the CNS. J Neurosci. 2008 Jul 09; 28(28):7174-83.
    View in: PubMed
    Score: 0.068
  53. LeVine SM, Macklin WB. Biotin enrichment in oligodendrocytes in the rat brain. Brain Res. 1988 Mar 15; 444(1):199-203.
    View in: PubMed
    Score: 0.066
  54. Malone KE, Stohlman SA, Ramakrishna C, Macklin W, Bergmann CC. Induction of class I antigen processing components in oligodendroglia and microglia during viral encephalomyelitis. Glia. 2008 Mar; 56(4):426-35.
    View in: PubMed
    Score: 0.066
  55. Murtie JC, Macklin WB, Corfas G. Morphometric analysis of oligodendrocytes in the adult mouse frontal cortex. J Neurosci Res. 2007 Aug 01; 85(10):2080-6.
    View in: PubMed
    Score: 0.064
  56. Wight PA, Duchala CS, Shick HE, Gudz TI, Macklin WB. Expression of a myelin proteolipid protein (Plp)-lacZ transgene is reduced in both the CNS and PNS of Plp(jp) mice. Neurochem Res. 2007 Feb; 32(2):343-51.
    View in: PubMed
    Score: 0.061
  57. Gonz?lez JM, Bergmann CC, Ramakrishna C, Hinton DR, Atkinson R, Hoskin J, Macklin WB, Stohlman SA. Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination. Am J Pathol. 2006 Mar; 168(3):796-804.
    View in: PubMed
    Score: 0.058
  58. Tsai HH, Macklin WB, Miller RH. Netrin-1 is required for the normal development of spinal cord oligodendrocytes. J Neurosci. 2006 Feb 15; 26(7):1913-22.
    View in: PubMed
    Score: 0.058
  59. Gao L, Macklin W, Gerson J, Miller RH. Intrinsic and extrinsic inhibition of oligodendrocyte development by rat retina. Dev Biol. 2006 Feb 15; 290(2):277-86.
    View in: PubMed
    Score: 0.057
  60. Gonz?lez JM, Bergmann CC, Fuss B, Hinton DR, Kangas C, Macklin WB, Stohlman SA. Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes. Glia. 2005 Jul; 51(1):22-34.
    View in: PubMed
    Score: 0.055
  61. Papay R, Gaivin R, McCune DF, Rorabaugh BR, Macklin WB, McGrath JC, Perez DM. Mouse alpha1B-adrenergic receptor is expressed in neurons and NG2 oligodendrocytes. J Comp Neurol. 2004 Oct 04; 478(1):1-10.
    View in: PubMed
    Score: 0.052
  62. Fox MA, Colello RJ, Macklin WB, Fuss B. Phosphodiesterase-Ialpha/autotaxin: a counteradhesive protein expressed by oligodendrocytes during onset of myelination. Mol Cell Neurosci. 2003 Jul; 23(3):507-19.
    View in: PubMed
    Score: 0.048
  63. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, Metzger D, Macklin WB, Chambon P, Suter U. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci. 2003 Apr; 22(4):430-40.
    View in: PubMed
    Score: 0.047
  64. Miller MJ, Haxhiu MA, Georgiadis P, Gudz TI, Kangas CD, Macklin WB. Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat. J Neurosci. 2003 Mar 15; 23(6):2265-73.
    View in: PubMed
    Score: 0.047
  65. Frazier AP, Mitchell DN, Given KS, Hunn G, Burch AM, Childs CR, Moreno-Garcia M, Corigilano MR, Quillinan N, Macklin WB, Herson PS, Dingman AL. Chronic changes in oligodendrocyte sub-populations after middle cerebral artery occlusion in neonatal mice. Glia. 2023 06; 71(6):1429-1450.
    View in: PubMed
    Score: 0.047
  66. Doerflinger NH, Macklin WB, Popko B. Inducible site-specific recombination in myelinating cells. Genesis. 2003 Jan; 35(1):63-72.
    View in: PubMed
    Score: 0.046
  67. Baracskay KL, Duchala CS, Miller RH, Macklin WB, Trapp BD. Oligodendrogenesis is differentially regulated in gray and white matter of jimpy mice. J Neurosci Res. 2002 Dec 01; 70(5):645-54.
    View in: PubMed
    Score: 0.046
  68. Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Spooren W, Fuss B, Mallon B, Macklin WB, Fujiwara H, Hasegawa M, Iwatsubo T, Kretzschmar HA, Haass C. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep. 2002 Jun; 3(6):583-8.
    View in: PubMed
    Score: 0.044
  69. Khandker L, Jeffries MA, Chang YJ, Mather ML, Evangelou AV, Bourne JN, Tafreshi AK, Ornelas IM, Bozdagi-Gunal O, Macklin WB, Wood TL. Cholesterol biosynthesis defines oligodendrocyte precursor heterogeneity between brain and spinal cord. Cell Rep. 2022 03 01; 38(9):110423.
    View in: PubMed
    Score: 0.044
  70. Spassky N, Goujet-Zalc C, Parmantier E, Olivier C, Martinez S, Ivanova A, Ikenaka K, Macklin W, Cerruti I, Zalc B, Thomas JL. Multiple restricted origin of oligodendrocytes. J Neurosci. 1998 Oct 15; 18(20):8331-43.
    View in: PubMed
    Score: 0.035
  71. Wight PA, Dobretsova A, Macklin WB. Regulation of murine myelin proteolipid protein gene expression. J Neurosci Res. 1997 Dec 15; 50(6):917-27.
    View in: PubMed
    Score: 0.033
  72. Li Y, Dunphy JM, Pedraza CE, Lynch CR, Cardona SM, Macklin WB, Lynch WP. Ecotropic Murine Leukemia Virus Infection of Glial Progenitors Interferes with Oligodendrocyte Differentiation: Implications for Neurovirulence. J Virol. 2016 Jan 13; 90(7):3385-99.
    View in: PubMed
    Score: 0.029
  73. Wight PA, Duchala CS, Readhead C, Macklin WB. A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice. J Cell Biol. 1993 Oct; 123(2):443-54.
    View in: PubMed
    Score: 0.024
  74. Shirazi Y, Rus HG, Macklin WB, Shin ML. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J Immunol. 1993 May 15; 150(10):4581-90.
    View in: PubMed
    Score: 0.024
  75. Hu X, Schlanger R, He W, Macklin WB, Yan R. Reversing hypomyelination in BACE1-null mice with Akt-DD overexpression. FASEB J. 2013 May; 27(5):1868-73.
    View in: PubMed
    Score: 0.023
  76. Hussain R, El-Etr M, Gaci O, Rakotomamonjy J, Macklin WB, Kumar N, Sitruk-Ware R, Schumacher M, Ghoumari AM. Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology. 2011 Oct; 152(10):3820-31.
    View in: PubMed
    Score: 0.021
  77. Rasband M, Bansal R, Macklin W, de Vellis J. Editorial. J Neurosci Res. 2009 Nov 15; 87(15):3239-40.
    View in: PubMed
    Score: 0.019
  78. Lee KK, de Repentigny Y, Saulnier R, Rippstein P, Macklin WB, Kothary R. Dominant-negative beta1 integrin mice have region-specific myelin defects accompanied by alterations in MAPK activity. Glia. 2006 Jun; 53(8):836-44.
    View in: PubMed
    Score: 0.015
  79. Yin X, Baek RC, Kirschner DA, Peterson A, Fujii Y, Nave KA, Macklin WB, Trapp BD. Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol. 2006 Jan 30; 172(3):469-78.
    View in: PubMed
    Score: 0.014
  80. Macklin WB, Weill CL, Deininger PL. Expression of myelin proteolipid and basic protein mRNAs in cultured cells. J Neurosci Res. 1986; 16(1):203-17.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)